| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/10/1997 | CN1159209A Recombinant herpesvirus with the use of gB Gene promoter |
| 09/10/1997 | CN1159186A Carbamazepine hydrazides useful in immunoassays |
| 09/10/1997 | CN1158856A Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/10/1997 | CN1035801C Microgranular preparation useful in delivery of biologically active materials to intestinal regious of animals |
| 09/09/1997 | US5665876 Acylation, amidation |
| 09/09/1997 | US5665873 Inhibits reactivation of herpes virus |
| 09/09/1997 | US5665870 Method of purifying keratinocyte growth factor (KGF) |
| 09/09/1997 | US5665865 Metal binding proteins |
| 09/09/1997 | US5665862 Neurotrophic factor |
| 09/09/1997 | US5665859 Molecules influencing the shedding of the TNF receptor, their preparation and their use |
| 09/09/1997 | US5665772 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 09/09/1997 | US5665592 Feline immunodeficiency virus isolate NCSU1 |
| 09/09/1997 | US5665577 Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof |
| 09/09/1997 | US5665566 Cloning of enterokinase and method of use |
| 09/09/1997 | US5665565 Transfection of enteric parasites |
| 09/09/1997 | US5665552 Antibodies to plasmodium falciparum |
| 09/09/1997 | US5665548 Characterization and detection of sequences associated with autoimmune diseases |
| 09/09/1997 | US5665542 Toxoplasma gondii P28 gene and methods for its use |
| 09/09/1997 | US5665537 Testing human body fluids for antibodies |
| 09/09/1997 | US5665536 Contacting a sample of body fluid with a polyclonal or monoclonal antibody and measuring the formation of antigen-antibody complexes |
| 09/09/1997 | US5665535 Polypeptides encoded by DNA sequences derived from the genome of the papillomavirus HPV39, antibodies thereto, and their use in in vitro diagnosis |
| 09/09/1997 | US5665389 Insulin, vibrio cholera zonula occludens toxin |
| 09/09/1997 | US5665380 Lipid vesicle fusion as a method of transmitting a biologically active material to a cell |
| 09/09/1997 | US5665362 Viral vaccines |
| 09/09/1997 | US5665360 Applying capsicum oleoresin |
| 09/09/1997 | US5665358 Antibody drug-conjugates |
| 09/09/1997 | US5665357 Antibodies recognizing tumor associated antigen CA 55.1 |
| 09/09/1997 | US5665356 Human anti-Rh (D) monoclonal antibodies |
| 09/09/1997 | US5665353 Composition containing an analog of haemophilus Hin47 with reduced protease activity |
| 09/09/1997 | CA1339445C Recombinant hybrid immunoglobulin molecules and method of use |
| 09/04/1997 | WO1997032029A1 Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 09/04/1997 | WO1997032026A1 Adapter molecules for targeting viral particles to cells |
| 09/04/1997 | WO1997032021A1 Therapeutic agents based on monoclonal anti-idiotypic antibody 105ad7 |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031948A1 Peptide immunogens for vaccination against and treatment of allergy |
| 09/04/1997 | WO1997031931A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | WO1997031655A2 Modified cytokines for therapeutic use |
| 09/04/1997 | WO1997031651A1 Porcine reproductive and respiratory syndrome vaccine |
| 09/04/1997 | WO1997022699A3 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 09/04/1997 | DE19639601A1 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen Parapox virus containing the foreign DNA, their preparation and their use in vaccines |
| 09/04/1997 | CA2247827A1 A novel disintegrin metalloprotease and methods of use |
| 09/04/1997 | CA2247308A1 Modified cytokines for therapeutic use |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792365A1 Immunogens for stimulating mucosal immunity |
| 09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
| 09/03/1997 | EP0792358A2 A polynucleotide tuberculosis vaccine |
| 09/03/1997 | EP0792354A1 Targeted t lymphocytes |
| 09/03/1997 | EP0792347A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 09/03/1997 | EP0792294A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
| 09/03/1997 | EP0792282A1 Human endothelin-bombesin receptor |
| 09/03/1997 | EP0792279A1 Antibiotic cryptdin peptides and methods of their use |
| 09/03/1997 | EP0792165A1 Immunogenic compositions |
| 09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 09/03/1997 | EP0792161A1 Hydrogel microencapsulated vaccines |
| 09/03/1997 | EP0792157A1 Preparation of mhc-peptide complexes |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | EP0542923B1 Liposomes that provide thymic dependent help to weak vaccine antigens |
| 09/03/1997 | CN1158623A New immunocotraceptive peptides |
| 09/03/1997 | CN1158572A Peroral immunogen compsn. and process for producing the same |
| 09/03/1997 | CN1158566A Pharmaceutical compsn. for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for treatment thereof |
| 09/03/1997 | CN1158219A Immunity dairy products of prevention of human body alimentary canal pathogeny microorganism |
| 09/02/1997 | US5663481 Animal model of the human immune system |
| 09/02/1997 | US5663317 Microorganism having attenuated invasiveness |
| 09/02/1997 | US5663293 ICAM-related protein |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5663065 Cloning rubella virus genomic rna for vaccines |
| 09/02/1997 | US5662911 Benzodiazepine protein conjugates |
| 09/02/1997 | US5662910 Antiprotozoa |
| 09/02/1997 | US5662909 Potentiation of immunogenic response |
| 09/02/1997 | US5662907 Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
| 09/02/1997 | US5662905 Protection against pseudomonas |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
| 09/02/1997 | CA1339412C Method for screening an expression cdna clone bank for the detection of polynucleotides |
| 08/29/1997 | CA2198316A1 Treatment of septic shock with anti-tnf antibodies |
| 08/28/1997 | WO1997031123A1 Vmp-like sequences of pathogenic borrelia |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031117A2 A human cytomegalovirus combined antigen and its use |
| 08/28/1997 | WO1997031115A2 Synthetic hiv genes |
| 08/28/1997 | WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 08/28/1997 | WO1997031025A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 08/28/1997 | WO1997031024A1 Antibody variants |
| 08/28/1997 | WO1997031017A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 08/28/1997 | WO1997030728A1 Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen |
| 08/28/1997 | WO1997030727A1 Immunogenic complex, iscom, for use in preparing a vaccine for juvenile individuals |
| 08/28/1997 | WO1997030726A1 Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| 08/28/1997 | WO1997030725A1 Cochleat delivery vehicles |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
| 08/28/1997 | WO1997009068A3 Interactive molecular conjugates |
| 08/28/1997 | DE19607044A1 Tumour vaccine containing tumour cells loaded with peptide(s) that bind to MHC Class I |
| 08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2245646A1 Synthetic hiv genes |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791360A2 Treatment of septic shock with anti-TNF antibodies |
| 08/27/1997 | EP0791359A1 Remedy for diseases caused by il-6 production |
| 08/27/1997 | EP0791068A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |